An Open Label Extension Trial of Eculizumab in Relapsing NMO Patients

Clinical trial NCT02003144 · COMPLETED

Trial details

NCT number: NCT02003144
Sponsor: Alexion Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Neuromyelitis Optica Neuromyelitis Optica Spectrum Disorder

Start date: 2015-01-12
Primary completion: 2021-07-12
Enrollment: 119

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.